L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro

Por Huang, Hongbiao, Liu, Ningning, Guo, Haiping, Liao, Siyan, Li, Xiaofen, Yang, Changshan, Liu, Shouting, Song, Wenbin, Liu, Chunjiao, Guan, Lixia, Li, Bing, Xu, Li, Zhang, Change, Wang, Xuejun, Dou, Q. Ping, Liu, Jinbao
Publicado em 2012

Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

Por Shi, Xianping, Chen, Xin, Li, Xiaofen, Lan, Xiaoying, Zhao, Chong, Liu, Shouting, Huang, Hongbiao, Liu, Ningning, Liao, Siyan, Song, Wenbin, Zhou, Ping, Wang, Shunqing, Xu, Li, Wang, Xuejun, Dou, Q. Ping, Liu, Jinbao
Publicado em 2013

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Por Chen, Xin, Shi, Xianping, Zhao, Chong, Li, Xiaofen, Lan, Xiaoying, Liu, Shouting, Huang, Hongbiao, Liu, Ningning, Liao, Siyan, Zang, Dan, Song, Wenbin, Liu, Quentin, Carter, Bing Z., Dou, Q. Ping, Wang, Xuejun, Liu, Jinbao
Publicado no Oncotarget (2014)

HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo

Por Huang, Hongbiao, Liu, Ningning, Yang, Changshan, Liao, Siyan, Guo, Haiping, Zhao, Kai, Li, Xiaofen, Liu, Shouting, Guan, Lixia, Liu, Chunjiao, Xu, Li, Zhang, Change, Song, Wenbin, Li, Bing, Tang, Ping, Dou, Q. Ping, Liu, Jinbao
Publicado em 2012

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

Por Zhao, Chong, Chen, Xin, Zang, Dan, Lan, Xiaoying, Liao, Siyan, Yang, Changshan, Zhang, Peiquan, Wu, Jinjie, Li, Xiaofen, Liu, Ningning, Liao, Yuning, Huang, Hongbiao, Shi, Xianping, Jiang, Lili, Liu, Xiuhua, He, Zhimin, Wang, Xuejun, Liu, Jinbao
Publicado no Biochem Pharmacol (2016)

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

Por Zhao, Chong, Chen, Xin, Yang, Changshan, Zang, Dan, Lan, Xiaoying, Liao, Siyan, Zhang, Peiquan, Wu, Jinjie, Li, Xiaofen, Liu, Ningning, Liao, Yuning, Huang, Hongbiao, Shi, Xianping, Jiang, Lili, Liu, Xiuhua, Ping, Q. Dou, Wang, Xuejun, Liu, Jinbao
Publicado no Oncotarget (2017)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

Por Liu, Ningning, Liu, Chunjiao, Li, Xiaofen, Liao, Siyan, Song, Wenbin, Yang, Changshan, Zhao, Chong, Huang, Hongbiao, Guan, Lixia, Zhang, Peiquan, Liu, Shouting, Hua, Xianliang, Chen, Xin, Zhou, Ping, Lan, Xiaoying, Yi, Songgang, Wang, Shunqing, Wang, Xuejun, Dou, Q. Ping, Liu, Jinbao
Publicado em 2014

Bilirubin neurotoxicity is associated with proteasome inhibition

Por Huang, Hongbiao, Guo, Mingxing, Liu, Ningning, Zhao, Chong, Chen, Haoyu, Wang, Xiaoli, Liao, Siyan, Zhou, Ping, Liao, Yuning, Chen, Xin, Lan, Xiaoying, Chen, Jinghong, Xu, Dacai, Li, Xiaofen, Shi, Xianping, Yu, Li, Nie, Yuqiang, Wang, Xuejun, Zhang, Chang-E, Liu, Jinbao
Publicado no Cell Death Dis (2017)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Por Liu, Ningning, Li, Xiaofen, Huang, Hongbiao, Zhao, Chong, Liao, Siyan, Yang, Changshan, Liu, Shouting, Song, Wenbin, Lu, Xiaoyu, Lan, Xiaoying, Chen, Xin, Yi, Songgang, Xu, Li, Jiang, Lili, Zhao, Canguo, Dong, Xiaoxian, Zhou, Ping, Li, Shujue, Wang, Shunqing, Shi, Xianping, Dou, Ping Q., Wang, Xuejun, Liu, Jinbao
Publicado em 2014